{"DataElement":{"publicId":"2967296","version":"1","preferredName":"Primary Malignant Neoplasm Anatomic Site Specify Text","preferredDefinition":"The free-text field to describe the anatomic site of the primary malignant neoplasm.","longName":"2967287v1.0:2799057v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2967287","version":"1","preferredName":"Primary Malignant Neoplasm Anatomic Site","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Named locations of or within the body.","longName":"2526559v1.0:2186622v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2526559","version":"1","preferredName":"Primary Malignant Neoplasm","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25251:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F768442-4F07-0998-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-10","endDate":null,"createdBy":"PWEST","dateCreated":"2006-10-10","modifiedBy":"ONEDATA","dateModified":"2006-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186622","version":"1","preferredName":"Anatomic Site","preferredDefinition":"Named locations of, or within, the body.","longName":"C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-B313-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-05","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":"Updated to point to NCI Thesaurus concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB133FF-9BF1-BF80-E040-BB89AD43245B","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"KUMMEROA","dateModified":"2017-07-04","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964916","version":"1","longName":"2126r1: Neuroblastoma Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]},{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7283433","version":"1","longName":"Baseline Evaluations","context":"AMC"}]}],"AlternateNames":[{"name":"neu_base_diag_oth_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_post_perst_oth_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"TargetAnatomicSite:code","type":"HCT_BRIDG","context":"NHLBI"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"PRICANC_MHTERM","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Specify other site:","type":"Alternate Question Text","description":"Specify other site:","url":null,"context":"NHLBI"},{"name":"Specify:","type":"Alternate Question Text","description":"Specify:","url":null,"context":"NHLBI"},{"name":"Specify the anatomic site of","type":"Preferred Question Text","description":"Specify the anatomic site of the primary tumor:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2967296","type":"BRIDG Mapping Path","description":"PerformedDiagnosis > TargetAnatomicSite.code(CD).originalText WHERE PerformedDiagnosis.value = \"Neuroblastoma\" AND TargetAnatomicSite.code(CD).nullFlavor = \"OTH\" AND PerformedDiagnosis > PerformedObservation > DefinedObservation.nameCode = \"evaluate for disease\"","url":null,"context":"NHLBI"},{"name":"DCP CRF text","type":"Alternate Question Text","description":"Target lesion (Primary tumor) location other specify","url":null,"context":"DCP"},{"name":"AMC Question Text","type":"Alternate Question Text","description":"If Yes, please identify the other primary cancer(s) (using ICDO3 or ICD10 codes)","url":null,"context":"AMC"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB133FF-9DBF-BF80-E040-BB89AD43245B","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"COLLIED","dateModified":"2022-04-25","changeDescription":".System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}